Skip to main content

What kind of company is Neurelis?

Neurelis is a neuroscience-based company with a unique portfolio of product candidates and innovative platform technologies. Along with our strategic partners, we are dedicated to enhancing therapeutic benefits and addressing significant unmet needs in patient care.

Neurelis was founded to license, develop, and commercialize product candidates for the broader central nervous system (CNS), including epilepsy and psychiatry. Our emphasis is on highly differentiated therapies that empower patients, care partners, and healthcare providers. The benefits of our unique platform technology allow us to form strategic partnerships to address significant unmet needs in other therapeutic areas as well.


The Neurelis team has a rich history of relevant neurology industry experience.

Meet the Leadership Team
Meet the Board of Directors